Related Experiment Videos
Con: allogeneic transplantation in multiple myeloma
1Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Clinical Advances in Hematology & Oncology : H&O
|May 27, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treating Castleman disease: insights into the use and efficacy of monoclonal antibodies.
Expert opinion on biological therapy·2026
How I Treat Plasma Cell Leukemia.
Blood·2026
Breast-implant associated unicentric castleman disease: a case report.
Current problems in cancer. Case reports·2026
Elucidating the grading intricacies of idiopathic multicentric Castleman disease histopathology: a pathologist's perspective.
American journal of clinical pathology·2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Clinical advances in hematology & oncology : H&O·2026
Hemophagocytic lymphohistiocytosis: new grading classification and targeted therapies.
Clinical advances in hematology & oncology : H&O·2026
Rituximab-based Induction in Vascularized Composite Allotransplantation: Prolonged Rejection-free Survival and the Role of Donor-specific Antibodies.
Plastic and reconstructive surgery. Global open·2026
Molecular diagnostics in pancreas transplantation: past, present, and future.
Frontiers in molecular biosciences·2026